DE60307721D1 - Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen - Google Patents
Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren SalzenInfo
- Publication number
- DE60307721D1 DE60307721D1 DE60307721T DE60307721T DE60307721D1 DE 60307721 D1 DE60307721 D1 DE 60307721D1 DE 60307721 T DE60307721 T DE 60307721T DE 60307721 T DE60307721 T DE 60307721T DE 60307721 D1 DE60307721 D1 DE 60307721D1
- Authority
- DE
- Germany
- Prior art keywords
- perindopril
- synthesis
- pharmaceutically acceptable
- acceptable salts
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03291931A EP1367063B1 (de) | 2003-07-31 | 2003-07-31 | Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60307721D1 true DE60307721D1 (de) | 2006-10-05 |
| DE60307721T2 DE60307721T2 (de) | 2007-10-18 |
Family
ID=29414890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60307721T Expired - Lifetime DE60307721T2 (de) | 2003-07-31 | 2003-07-31 | Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7358372B2 (de) |
| EP (1) | EP1367063B1 (de) |
| JP (1) | JP4263743B2 (de) |
| KR (1) | KR100798560B1 (de) |
| CN (1) | CN100404548C (de) |
| AR (1) | AR045151A1 (de) |
| AT (1) | ATE337332T1 (de) |
| AU (1) | AU2004261439B2 (de) |
| BR (1) | BRPI0413169A (de) |
| CA (1) | CA2533005C (de) |
| CY (1) | CY1105791T1 (de) |
| DE (1) | DE60307721T2 (de) |
| DK (1) | DK1367063T3 (de) |
| EA (1) | EA008685B1 (de) |
| ES (1) | ES2271498T3 (de) |
| GE (1) | GEP20094740B (de) |
| HK (1) | HK1096406A1 (de) |
| MA (1) | MA27911A1 (de) |
| MX (1) | MXPA06001243A (de) |
| MY (1) | MY139443A (de) |
| NO (1) | NO333957B1 (de) |
| NZ (1) | NZ544879A (de) |
| PL (1) | PL211892B1 (de) |
| PT (1) | PT1367063E (de) |
| SI (1) | SI1367063T1 (de) |
| UA (1) | UA80905C2 (de) |
| WO (1) | WO2005012333A2 (de) |
| ZA (1) | ZA200600479B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI21800A (sl) * | 2004-05-14 | 2005-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek sinteze perindoprila |
| WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
| FR3050380B1 (fr) | 2016-04-20 | 2020-07-10 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8604144A1 (es) * | 1984-11-21 | 1986-01-16 | Farmhispania | Procedimiento para la obtencion del acido (2s, 3as, 7as)-1-((s)-1-etoxicarbonil-3-fenilpropil) alanil) exahidro-2-indolincarboxilico |
| FR2807431B1 (fr) * | 2000-04-06 | 2002-07-19 | Adir | Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables |
| FR2827860B1 (fr) * | 2001-07-24 | 2004-12-10 | Servier Lab | Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril |
-
2003
- 2003-07-31 SI SI200330430T patent/SI1367063T1/sl unknown
- 2003-07-31 PT PT03291931T patent/PT1367063E/pt unknown
- 2003-07-31 ES ES03291931T patent/ES2271498T3/es not_active Expired - Lifetime
- 2003-07-31 AT AT03291931T patent/ATE337332T1/de active
- 2003-07-31 EP EP03291931A patent/EP1367063B1/de not_active Expired - Lifetime
- 2003-07-31 DK DK03291931T patent/DK1367063T3/da active
- 2003-07-31 DE DE60307721T patent/DE60307721T2/de not_active Expired - Lifetime
-
2004
- 2004-07-29 WO PCT/FR2004/002035 patent/WO2005012333A2/fr active Application Filing
- 2004-07-29 MX MXPA06001243A patent/MXPA06001243A/es active IP Right Grant
- 2004-07-29 CA CA2533005A patent/CA2533005C/fr not_active Expired - Fee Related
- 2004-07-29 BR BRPI0413169-0A patent/BRPI0413169A/pt active Search and Examination
- 2004-07-29 ZA ZA200600479A patent/ZA200600479B/en unknown
- 2004-07-29 UA UAA200602130A patent/UA80905C2/xx unknown
- 2004-07-29 US US10/566,562 patent/US7358372B2/en not_active Expired - Fee Related
- 2004-07-29 JP JP2006521621A patent/JP4263743B2/ja not_active Expired - Fee Related
- 2004-07-29 MY MYPI20043053A patent/MY139443A/en unknown
- 2004-07-29 EA EA200600250A patent/EA008685B1/ru not_active IP Right Cessation
- 2004-07-29 AU AU2004261439A patent/AU2004261439B2/en not_active Ceased
- 2004-07-29 KR KR1020067001920A patent/KR100798560B1/ko not_active IP Right Cessation
- 2004-07-29 PL PL379631A patent/PL211892B1/pl unknown
- 2004-07-29 AR ARP040102693A patent/AR045151A1/es not_active Application Discontinuation
- 2004-07-29 GE GEAP20049261A patent/GEP20094740B/en unknown
- 2004-07-29 CN CNB2004800212090A patent/CN100404548C/zh not_active Expired - Fee Related
- 2004-07-29 NZ NZ544879A patent/NZ544879A/en not_active IP Right Cessation
-
2006
- 2006-01-17 MA MA28731A patent/MA27911A1/fr unknown
- 2006-02-24 NO NO20060922A patent/NO333957B1/no not_active IP Right Cessation
- 2006-11-16 CY CY20061101673T patent/CY1105791T1/el unknown
-
2007
- 2007-02-01 HK HK07101182A patent/HK1096406A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60129800D1 (de) | Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salze | |
| ATE455106T1 (de) | Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen | |
| FR2868414B1 (fr) | Procede de production d'alpha-alumine particulaire et apha-alumine particulaire produite par ce procede | |
| HK1089187A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| DE60318839D1 (de) | 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten | |
| DE60311942D1 (de) | Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen | |
| EG24152A (en) | Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril | |
| DE60303101D1 (de) | Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen | |
| HK1096409A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| ATE365714T1 (de) | Verfahren zur herstellung von hochreinem perindopril und zwischenverbindungen nützlich in der synthese | |
| DE60300581D1 (de) | Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen | |
| DE60301820D1 (de) | Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen | |
| HK1096408A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| DE60319196D1 (de) | Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen | |
| DE60301930D1 (de) | Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salze | |
| DE60307925D1 (de) | Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen | |
| DE60307721D1 (de) | Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen | |
| DE60311730D1 (de) | Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen | |
| ATE534624T1 (de) | Verfahren und zwischenprodukte für die herstellung von n-(1-benzhydryl-azetidin-3-yl)-n- phenyl-methylsulphonamid-derivaten | |
| DE60336931D1 (de) | Verfahren zur synthese der bisbenzimidazolen und ihren derivaten. | |
| ATE344800T1 (de) | Substituierte [1,4öbenzodioxin[2,3-eöisoindol- derivaten, ihr verfahren zur herstellung und ihre pharmazeutische zusammensetzungen | |
| FR2861727B1 (fr) | Procede de synthese directe d'alkylhalogenosilanes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |